Updating of FIP policy statement on "The pharmacist's authority in product selection therapeutic interchange and generic substitution"

In 2017 members of Moscow Pharmaceutical Society (MPS) passed through the selection process and was included by International Pharmaceutical Federation (FIP) in the working group for updating the current FIP Policy Statement on "The Pharmacist’s Authority in Product Selection Therapeutic Interchange and Generic Substitution”, which was initially adopted in 1997.

Original document is available here.